Melatonin ameliorates metabolic risk factors, modulates apoptotic proteins, and protects the rat heart against diabetes-induced apoptosis

European Journal of Pharmacology

Volumn 747, Issue , 2015, Pages 166-173

  Amin, Ali H ^a   El Missiry, Mohamed A ^a   Othman, Azza I ^a  

^a Mansoura University   (Egypt)

Author keywords

Antioxidant; Cardiomyopathy; Diabetes; Lipids; Melatonin; Streptozotocin

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; CREATINE KINASE MB; FAS ANTIGEN; GLUTATHIONE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; LACTATE DEHYDROGENASE; LIPOCORTIN 5; LOW DENSITY LIPOPROTEIN; MELATONIN; PROTEIN BCL 2; PROTEIN P53; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; APOPTOSIS REGULATORY PROTEIN; CASPASE; CREATINE KINASE; GLYCOSYLATED HEMOGLOBIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; FLOW CYTOMETRY; GLYCOSYLATION; HEART MUSCLE; HEART PROTECTION; HEMOGLOBIN BLOOD LEVEL; MALE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; RISK FACTOR; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; ANIMAL; CELL PROTECTION; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; HEART; HEART MUSCLE CELL; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; WISTAR RAT;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CASPASES; CREATINE KINASE; CYTOPROTECTION; DIABETES MELLITUS, EXPERIMENTAL; DOWN-REGULATION; HEART; HEMOGLOBIN A, GLYCOSYLATED; LACTATE DEHYDROGENASES; MALE; MELATONIN; MYOCYTES, CARDIAC; OXIDATIVE STRESS; RATS; RATS, WISTAR; RISK FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84919797937     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2014.12.002     Document Type: Article

References (57)

1. A. Agil, M. Navarro-Alarcon, R. Ruiz, S. Abuhamadah, M.Y. El-Mir, and G.F. Vazquez Beneficial effects of melatonin on obesity and lipid profile in young Zucker diabetic fatty rats J. Pineal Res. 50 2011 207 212
2. A. Agil, I. Rosado, R. Ruiz, A. Figueroa, N. Zen, and G. Fernandez-Vazquez Melatonin improves glucose homeostasis in young Zucker diabetic fatty rats J. Pineal Res. 52 2012 203 210
3. N. Aksoy, H. Vural, T. Sabuncu, and S. Aksoy Effects of melatonin on oxidative-antioxidative status of tissues in streptozotocin-induced diabetic rats Cell Biochem. Funct. 21 2003 121 125
4. G. Baydas, R.J. Reiter, M. Akbulut, M. Tuzcu, and S. Tamer Melatonin inhibits neural apoptosis induced by homocysteine in hippocampus of rats via inhibition of cytochrome c translocation and caspase-3 activation and by regulating pro- and anti-apoptotic protein levels Neuroscience 135 2005 879 886
5. B.A. Bonsing, W.E. Corver, M.C. Gorsira, M. van Vliet, P.S. Oud, C.J. Cornelisse, and G.J. Fleuren Specificity of seven monoclonal antibodies against p53 evaluated with Western blotting, immunohistochemistry, confocal laser scanning microscopy, and flow cytometry Cytometry 28 1997 11 24
6. S. Boudina, and E.D. Abel Diabetic cardiomyopathy, causes and effects Rev. Endocr. Metab. Disord. 11 2010 31 39
7. L. Cai, W. Li, G. Wang, L. Guo, Y. Jiang, and Y.J. Kang Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway Diabetes 51 2002 1938 1948
8. A. Dominguez-Rodriguez, P. Abreu-Gonzalez, M. Garcia-Gonzalez, J. Ferrer-Hita, M. Vargas, and R.J. Reiter Elevated levels of oxidized low-density lipoprotein and impaired nocturnal synthesis of melatonin in patients with myocardial infarction Atherosclerosis 180 2005 101 105
9. A. Dominguez-Rodriguez, P. Abreu-Gonzalez, and R.J. Reiter Melatonin and cardiovascular disease: myth or reality? Rev. Esp. Cardiol. 65 2012 215 218
10. A. Dominguez-Rodriguez, P. Abreu-Gonzalez, and R.J. Reiter Cardioprotection and pharmacological therapies in acute myocardial infarction: challenges in the current era World J. Cardiol. 6 2014 100 106
11. M.A. El-Missiry, and A.M. El Gindy Amelioration of alloxan induced diabetes mellitus and oxidative stress in rats by oil of Eruca sativa seeds Ann. Nutr. Metab. 44 2000 97 100
12. M.A. El-Missiry, T.A. Fayed, M.R. El-Sawy, and A.A. El-Sayed Ameliorative effect of melatonin against gamma-irradiation-induced oxidative stress and tissue injury Ecotoxicol. Environ. Saf. 66 2007 278 286
13. M.A. El-Missiry, A.I. Othman, and M.A. Amer L-Arginine ameliorates oxidative stress in alloxan-induced experimental diabetes mellitus J. Appl. Toxicol. 24 2004 93 97
14. F. Fiordaliso, R. Bianchi, L. Staszewsky, I. Cuccovillo, M. Doni, T. Laragione, M. Salio, C. Savino, S. Melucci, F. Santangelo, E. Scanziani, S. Masson, P. Ghezzi, and R. Latini Antioxidant treatment attenuates hyperglycemia-induced cardiomyocyte death in rats J. Mol. Cell. Cardiol. 37 2004 959 968
15. T.V. Fiorentino, A. Prioletta, P. Zuo, and F. Folli Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases Curr. Pharm. Des. 19 2013 5695 5703
16. D. Garfinkel, M. Zorin, J. Wainstein, Z. Matas, M. Laudon, and N. Zisapel Efficacy and safety of prolonged-release melatonin in insomnia patients with diabetes: a randomized, double-blind, crossover study Diabetes Metab. Syndr. Obes. Target Ther. 4 2011 307 313
17. S. Ghosh, T. Pulinilkunnil, G. Yuen, G. Kewalramani, D. Qi, D. Abrahani, and A. Rodrigues, B. Cardiomyocyte apoptosis induced by short-term diabetes requires mitochondrial GSH depletion Am. J. Physiol. Heart Circ. Physiol. 289 2005 H768 H776
18. J. Gong, L. Qian, X. Kong, R. Yang, L. Zhou, Y. Sheng, W. Sun, F. Sun, Y. Huang, and K. Cao Cardiomyocyte apoptosis in the right auricle of patients with ostium secundum atrial septal defect diseases Life Sci. 80 2007 1143 1151
19. I. Grigorov, D. Bogojevic, S. Jovanovic, A. Petrovic, S. Ivanovic-Matic, L. Zolotarevski, G. Poznanovic, and V. Martinovic Hepatoprotective effects of melatonin against pronecrotic cellular events in streptozotocin-induced diabetic rats J. Physiol. Biochem. 70 2014 441 450
20. H. He, W. Dong, and F. Huang Anti-amyloidogenic and anti-apoptotic role of melatonin in Alzheimer disease Curr. Neuropharmacol. 8 2010 211 217
21. D. Jay, H. Hitomi, and K.K. Griendling Oxidative stress and diabetic cardiovascular complications Free Radic. Biol. Med. 40 2006 183 192
22. W.S. Juan, H.W. Lin, Y.H. Chen, H.Y. Chen, Y.C. Hung, S.H. Tai, S.Y. Huang, T.Y. Chen, and E.J. Lee Optimal Percoll concentration facilitates flow cytometric analysis for annexin V/propidium iodine-stained ischemic brain tissues Cytometry Part A 81 2012 400 408
23. M. Kanter, H. Uysal, T. Karaca, and H.O. Sagmanligil Depression of glucose levels and partial restoration of pancreatic beta-cell damage by melatonin in streptozotocin-induced diabetic rats Arch. Toxicol. 80 2006 362 369
24. 2 Oxid. Med. Cell. Longev. 2014 2014 (657512)
25. G.G. Korkmaz, H. Uzun, U. Cakatay, and S. Aydin Melatonin ameliorates oxidative damage in hyperglycemia-induced liver injury Clin. Investig. Med. 35 2012 E370 E377
26. A. Leonardini, and A. Avogaro Abnormalities of the cardiac stem and progenitor cell compartment in experimental and human diabetes Arch. Physiol. Biochem. 119 2013 179 187
27. G. Letechipia-Vallejo, I. Gonzalez-Burgos, and M. Cervantes Neuroprotective effect of melatonin on brain damage induced by acute global cerebral ischemia in cats Arch. Med. Res. 32 2001 186 192
28. C.J. Li, L. Lv, H. Li, and D.M. Yu Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid Cardiovasc. Diabetol. 11 2012 73
29. S. Lopez-Burillo, D.X. Tan, J.C. Mayo, R.M. Sainz, L.C. Manchester, and R.J. Reiter Melatonin, xanthurenic acid, resveratrol, EGCG, vitamin C and alpha-lipoic acid differentially reduce oxidative DNA damage induced by Fenton reagents: a study of their individual and synergistic actions J. Pineal Res. 34 2003 269 277
30. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J. Biol. Chem. 193 1951 265 275
31. F. Luchetti, B. Canonico, M. Betti, M. Arcangeletti, F. Pilolli, M. Piroddi, L. Canesi, S. Papa, and F. Galli Melatonin signaling and cell protection function FASEB J. 24 2010 3603 3624
32. M. Martinez-Alfaro, D. Hernandez-Cortes, K. Wrobel, G. Cruz-Jimenez, J.C. Rivera-Leyva, R.M. Pina-Zentella, and A. Carabez Trejo Effect of melatonin administration on DNA damage and repair responses in lymphocytes of rats subchronically exposed to lead Mutat. Res. 742 2012 37 42
33. J.C. Mayo, D.X. Tan, R.M. Sainz, M. Natarajan, S. Lopez-Burillo, and R.J. Reiter Protection against oxidative protein damage induced by metal-catalyzed reaction or alkylperoxyl radicals: comparative effects of melatonin and other antioxidants Biochim. Biophys. Acta 1620 2003 139 150
34. I. Mehmeti, S. Lenzen, and S. Lortz Modulation of Bcl-2-related protein expression in pancreatic beta cells by pro-inflammatory cytokines and its dependence on the antioxidative defense status Mol. Cell. Endocrinol. 332 2011 88 96
35. J. Michaelson, V. Hariharan, and H. Huang Hyperglycemic and hyperlipidemic conditions alter cardiac cell biomechanical properties Biophys. J. 106 2014 2322 2329
36. D. Mukherjee, S.G. Roy, A. Bandyopadhyay, A. Chattopadhyay, A. Basu, E. Mitra, A.K. Ghosh, R.J. Reiter, and D. Bandyopadhyay Melatonin protects against isoproterenol-induced myocardial injury in the rat: antioxidative mechanisms J. Pineal Res. 48 2010 251 262
37. V. Patel, A. Upaganlawar, R. Zalawadia, and R. Balaraman Cardioprotective effect of melatonin against isoproterenol induced myocardial infarction in rats: a biochemical, electrocardiographic and histoarchitectural evaluation Eur. J. Pharmacol. 644 2010 160 168
38. I.G. Poornima, P. Parikh, and R.P. Shannon Diabetic cardiomyopathy: the search for a unifying hypothesis Circ. Res. 98 2006 596 605
39. F. Radogna, M. Diederich, and L. Ghibelli Melatonin: a pleiotropic molecule regulating inflammation Biochem. Pharmacol. 80 2010 1844 1852
40. R.J. Reiter, D.X. Tan, L.C. Manchester, S. Lopez-Burillo, R.M. Sainz, and J.C. Mayo Melatonin: detoxification of oxygen and nitrogen-based toxic reactants Adv. Exp. Med. Biol. 527 2003 539 548
41. R.J. Reiter, D.X. Tan, S. Rosales-Corral, and L.C. Manchester The universal nature, unequal distribution and antioxidant functions of melatonin and its derivatives Mini Rev. Med. Chem. 13 2013 373 384
42. R. Robeva, G. Kirilov, A. Tomova, and P. Kumanov Melatonin-insulin interactions in patients with metabolic syndrome J. Pineal Res. 44 2008 52 56
43. J.E. Roeters van Lennep, H.T. Westerveld, D.W. Erkelens, and E.E. van der Wall Risk factors for coronary heart disease: implications of gender Cardiovasc. Res. 53 2002 538 549
44. K.H. Sabeena Farvin, R. Anandan, S.H. Kumar, K.S. Shiny, T.V. Sankar, and T.K. Thankappan Effect of squalene on tissue defense system in isoproterenol-induced myocardial infarction in rats Pharmacol. Res. 50 2004 231 236
45. R.M. Sainz, J.C. Mayo, R.J. Reiter, I. Antolin, M.M. Esteban, and C. Rodriguez Melatonin regulates glucocorticoid receptor: an answer to its antiapoptotic action in thymus FASEB J. 13 1999 1547 1556
46. G. Saravanan, and J. Prakash Effect of garlic (Allium sativum) on lipid peroxidation in experimental myocardial infarction in rats J. Ethnopharmacol. 94 2004 155 158
47. C. Sartori, P. Dessen, C. Mathieu, A. Monney, J. Bloch, P. Nicod, U. Scherrer, and H. Duplain Melatonin improves glucose homeostasis and endothelial vascular function in high-fat diet-fed insulin-resistant mice Endocrinology 150 2009 5311 5317
48. N. Simsek, M. Kaya, A. Kara, I. Can, A. Karadeniz, and Y. Kalkan Effects of melatonin on islet neogenesis and beta cell apoptosis in streptozotocin-induced diabetic rats: an immunohistochemical study Domest. Anim. Endocrinol. 43 2012 47 57
49. Y. Singh, M.K. Garg, N. Tandon, and R.K. Marwaha A study of insulin resistance by HOMA-IR and its cut-off value to identify metabolic syndrome in urban Indian adolescents J. Clin. Res. Pediatr. Endocrinol. 5 2013 245 251
50. N.K. Singhal, G. Srivastava, D.K. Patel, S.K. Jain, and M.P. Singh Melatonin or silymarin reduces maneb- and paraquat-induced Parkinson's disease phenotype in the mouse J. Pineal Res. 50 2011 97 109
51. B.K. Tan, C.H. Tan, and P.N. Pushparaj Anti-diabetic activity of the semi-purified fractions of Averrhoa bilimbi in high fat diet fed-streptozotocin-induced diabetic rats Life Sci. 76 2005 2827 2839
52. S. Tengattini, R.J. Reiter, D.X. Tan, M.P. Terron, L.F. Rodella, and R. Rezzani Cardiovascular diseases: protective effects of melatonin J. Pineal Res. 44 2008 16 25
53. R.A. Thandavarayan, V.V. Giridharan, K. Watanabe, and T. Konishi Diabetic cardiomyopathy and oxidative stress: role of antioxidants Cardiovasc. Hematol. Agents Med. Chem. 9 2011 225 230
54. H. Vural, T. Sabuncu, S.O. Arslan, and N. Aksoy Melatonin inhibits lipid peroxidation and stimulates the antioxidant status of diabetic rats J. Pineal Res. 31 2001 193 198
55. X. Wang, B.E. Figueroa, I.G. Stavrovskaya, Y. Zhang, A.C. Sirianni, S. Zhu, A.L. Day, B.S. Kristal, and R.M. Friedlander Methazolamide and melatonin inhibit mitochondrial cytochrome C release and are neuroprotective in experimental models of ischemic injury Stroke 40 2009 1877 1885
56. I.B. Zavodnik, A.V. Domanski, E.A. Lapshina, M. Bryszewska, and R.J. Reiter Melatonin directly scavenges free radicals generated in red blood cells and a cell-free system: chemiluminescence measurements and theoretical calculations Life Sci. 79 2006 391 400
57. Y. Zhang, A. Cook, J. Kim, S.V. Baranov, J. Jiang, K. Smith, K. Cormier, E. Bennett, R.P. Browser, A.L. Day, D.L. Carlisle, R.J. Ferrante, X. Wang, and R.M. Friedlander Melatonin inhibits the caspase-1/cytochrome c/caspase-3 cell death pathway, inhibits MT1 receptor loss and delays disease progression in a mouse model of amyotrophic lateral sclerosis Neurobiol. Dis. 55 2013 26 35